Source material behind every call on the tape.
So I'm sure a lot of us have experienced some dramatic run ups in the past few years. One of mine is Corning (GLW) I bought it yearssss ago when it wasn't cool with an average cost of $35. Now …
TOYO Co., Ltd (Ticker: TOYO) looks like a mispriced growth stock that swung to profitability but got slaughtered by retail panic selling. I’m considering opening a position and would love to get this subs opinion on this one. TOYO is …
TL;DR: The 🌈🐻 jannies at WSB nuked my god-tier Ape DD from the front page because they hate money, so I'm dropping it here for you fellow degenerates instead. 🦍💎🙌🚀 Visited a Wendy's in Indonesia and it was packed to …
Another set of company write-ups from Substack authors, all from within the last week. Not my work - sourced from Giles Capital's weekly compilation: [https://gilescapital.substack.com/](https://gilescapital.substack.com/) # Americas **Elliot's Musings** on [**Micron Technology**](https://alphaseeker84.substack.com/p/micron-technology-mu-q3-fy2026-results) (🇺🇸 MU US - US$1.3tn) Latest quarter beat …
The market seems to think it has Mattel figured out - (I miss you, em dash) a floundering toy maker that can only hope for a consumer discretionary recovery. Softer than expected demand for its toys over the holiday season …
this sounds obvious but it wasn't obvious to me when i started swing trading i used to enter a swing trade and just manage it based on price action. set a stop, let it run, trail the stop when it …
on 1D interval, beginning Feb11th until present. Looks like VCP to me; something to watch.
JOIN FOR $8/YEARThe views and opinions expressed here are solely my own and do not represent those of my employer, any affiliated organization, or any institution with which I am associated.Friends! This photo shows what I wish I could do …
This stock keeps climbing.. The combination of a Phase 3 breast cancer trial underway, a potential accelerated approval path in vascular anomalies, FDA Breakthrough status, and two years of cash is a pretty compelling setup for a clinical-stage biotech. Every …
AI bubble is ready to burst